PE Fund Investments
Everstone acquires controlling stake in Softgel Healthcare
Private Equity firm Everstone Capital has acquired a controlling stake in Chennai-based Softgel Healthcare (SHPL), a player catering to nutraceutical, pharmaceutical and OTC segments. Puncham Mukim and Arjun Oberoi, Managing Directors, Everstone Capital will join the board of SHPL. Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders. Led by its CEO Dr Vijay Alagappan, SHPL is part of the Madras Pharma Group, with 8 manufacturing facilities covering all dosage forms. SHPL claims to have customer relationships in over 40 countries. The deal will help transform SHPL into a scaled, diversified, and globally recognized contract research, development, and manufacturing organization (CDMO) in India with support of the strategic resources of Everstone.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
